Pyramax

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

94 competitors in Malaria

#DrugCompanyPhaseTrials

1

Dihydroartemisinin-Piperaquine

GSK

Phase 3

512

Rabies Vaccine

Novartis

Phase 3

93

YF-Vax

Sanofi

Phase 3

14

Krintafel

GGlaxo Dba Glaxosmithkline

Phase 3

45

Artemether-Lumefantrine (AL)

Novartis

Phase 3

116

Artesunate-Amodiaquine

Sanofi

Phase 3

197

Pfspz Challenge

Merck & Co.

Phase 2

118

R21/matrix-M

UUniversity of Oxford

Phase 3

49

Pyramax

SShin Poong Pharmaceutical Co. Ltd.

Phase 3

210

Hexavalent Vaccine

Sanofi

Phase 2

1Show 19 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

COVID-192 trials

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Completed·SShin Poong Pharmaceutical Co. Ltd.·Phase 2·NCT05633420·20 enrolled

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

Completed·SShin Poong Pharmaceutical Co. Ltd.·Phase 3·NCT05084911·1,807 enrolled

Malaria2 trials

Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)

Completed·—·Phase 3·NCT04783051·250 enrolled

A Randomized, Open-Label Crossover Study to Evaluate Potential Pharmacokinetic Interactions of Orally Administered Piperaquine, Pyronaridine and Artesunate in Healthy Adult Participants

Not yet recruiting·UUniversity of Oxford·Phase 1·NCT07470424·24 enrolled

Interaction1 trial

Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Study

Completed·Medicines for Malaria Venture·Phase 1·NCT01156389·34 enrolled

Details

Drug Info

Related News